Related Experiment Video
Updated: Dec 15, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Correlation between ischemia-modified albumin level and coronary collateral circulation
Xin Chen1, Yan Lin1, Lihua Tian1
1Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China.
Insights
Higher levels of ischemia-modified albumin (IMA) correlate with good coronary collateral circulation (CCC) formation in patients with chronic total occlusions (CTO). IMA serves as a valuable predictor for assessing CCC in these patients.
Area of Science:
- Cardiology
- Biomarkers
- Vascular Biology
Background:
- Coronary artery disease (CAD) remains a leading cause of mortality worldwide.
- Chronic total occlusions (CTO) represent a significant challenge in CAD management.
- Coronary collateral circulation (CCC) plays a crucial role in mitigating ischemic damage in CTO patients.
Purpose of the Study:
- To investigate the correlation between ischemia-modified albumin (IMA) levels and the degree of coronary collateral circulation (CCC) in patients with CTO.
- To evaluate IMA as a potential predictor of good CCC formation in CTO.
Main Methods:
- A cohort of 128 patients with CTO lesions were analyzed.
- CCC was assessed using the Rentrop classification system.
- IMA levels were measured using an albumin-cobalt binding assay.
Main Results:
- Patients with poor CCC formation had higher platelet counts and diabetes prevalence.
- Ischemia-modified albumin (IMA) levels were significantly lower in patients with poor CCC.
- Multivariate analysis revealed IMA as a positive predictor of good CCC formation (OR=1.190, P<0.001).
Conclusions:
- IMA levels are closely associated with good CCC formation in CTO patients.
- Elevated IMA levels can effectively predict good CCC development.
- IMA represents a promising biomarker for assessing collateralization in CTO.
Objective:
To investigate the correlation between ischemia-modified albumin (IMA) levels and coronary collateral circulation (CCC) in patients with chronic total occlusive (CTO).
Methods:
Coronary angiography was performed in the Department of Cardiology, Zhongnan Hospital of Wuhan University from 2017 to 08 to 2019-02 to identify 128 patients with CTO lesions in at least one major coronary artery. According to the Rentrop evaluation criteria, the degree of CCC formation was divided into the poor CCC formation group (Rentrop0-1 grade,n = 69) and the good CCC formation group (Rentrop2-3 grade,n = 59). The IMA level of the patients was measured using an albumin-cobalt binding assay. The general data, routine blood panel, total bilirubin (TBIL), blood lipids, uric acid (UA), left ventricular ejection fraction (LVEF) and other indicators of the patients were recorded and analyzed while assessing the patients' blood vessel occlusion.
Results:
The proportion of platelet count and diabetes in the poor CCC group was higher than that in the good CCC group (P < 0.05). The ratio of ischemia-modified albumin and total bilirubin in the poor CCC group was lower than that in the good CCC group (P < 0.05). Multivariate logistic regression analysis showed that ischemia-modified albumin was positively correlated with CCC formation [OR = 1.190,95% CI (1.092-1.297),P < 0.001], while diabetes was negatively correlated with CCC formation [OR = 0.285,95% CI (0.094-0.864), P < 0.05]. Ischemic modified albumin predicted good formation of CCC according to the ROC curve, and the area under the ROC curve was 0.769(95% CI,0.686-0.851, P<0.001); the optimal cut-off value was 63.35 KU/L, and the sensitivity was 71.2%,specificity is 71%.
Conclusion:
The IMA level is closely related to good formation of CCC. Higher IMA levels can be used as an effective predictor of good CCC formation in patients with CTO.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies

